News summaryJ-Star Holding via GlobeNewswireNov 9, 2026, 12:00 PM
Editas Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates
EDITcorporate_earnings
Editas Medicine announced its financial results for the third quarter of 2026 and shared positive preclinical data for its EDIT-401 program.